China Recombinant DNA Vaccines Market Research Report Forecast 2017-2021
The China Recombinant DNA Vaccines Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Recombinant DNA Vaccines industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Recombinant DNA Vaccines market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
ALK - Abello A/S (Denmark)
Altimmune, Inc. (US)
Bavarian Nordic A/S (Denmark)
BiondVax Pharmaceuticals Ltd. (Israel)
Bharat Biotech International Limited (India)
GlaxoSmithKline Plc. (UK)
Hualan Biological Engineering Inc. (China)
Janssen Pharmaceuticals, Inc. (US)
MedImmune (US)
China Recombinant DNA Vaccines Market: Product Segment Analysis
Type 1
Type 2
Type 3
China Recombinant DNA Vaccines Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
This report provides comprehensive analysis of
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
ALK - Abello A/S (Denmark)
Altimmune, Inc. (US)
Bavarian Nordic A/S (Denmark)
BiondVax Pharmaceuticals Ltd. (Israel)
Bharat Biotech International Limited (India)
GlaxoSmithKline Plc. (UK)
Hualan Biological Engineering Inc. (China)
Janssen Pharmaceuticals, Inc. (US)
MedImmune (US)
China Recombinant DNA Vaccines Market: Product Segment Analysis
Type 1
Type 2
Type 3
China Recombinant DNA Vaccines Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 RECOMBINANT DNA VACCINES MARKET OVERVIEW
1.1 Product Overview and Scope of Recombinant DNA Vaccines
1.2 Recombinant DNA Vaccines Market Segmentation by Type
1.2.1 China Production Market Share of Recombinant DNA Vaccines by Type 1n 2016
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Recombinant DNA Vaccines Market Segmentation by Application
1.3.1 Recombinant DNA Vaccines Consumption Market Share by Application in 2016
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Recombinant DNA Vaccines (2012-2021)
CHAPTER 2 CHINA ECONOMIC IMPACT ON RECOMBINANT DNA VACCINES INDUSTRY
2.1 China Macroeconomic Environment Analysis
2.1.1 China Macroeconomic Analysis
2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Recombinant DNA Vaccines Industry
CHAPTER 3 CHINA RECOMBINANT DNA VACCINES MARKET COMPETITION BY MANUFACTURERS
3.1 China Recombinant DNA Vaccines Production and Share by Manufacturers (2015 and 2016)
3.2 China Recombinant DNA Vaccines Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Recombinant DNA Vaccines Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Recombinant DNA Vaccines Manufacturing Base Distribution, Production Area and Product Type
3.5 Recombinant DNA Vaccines Market Competitive Situation and Trends
3.5.1 Recombinant DNA Vaccines Market Concentration Rate
3.5.2 Recombinant DNA Vaccines Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 CHINA RECOMBINANT DNA VACCINES CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)
4.1 China Recombinant DNA Vaccines Capacity, Production and Growth (2012-2017)
4.2 China Recombinant DNA Vaccines Revenue and Growth (2012-2017)
4.3 China Recombinant DNA Vaccines Production, Consumption, Export and Import (2012-2017)
CHAPTER 5 CHINA RECOMBINANT DNA VACCINES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
5.1 China Recombinant DNA Vaccines Production and Market Share by Type (2012-2017)
5.2 China Recombinant DNA Vaccines Revenue and Market Share by Type (2012-2017)
5.3 China Recombinant DNA Vaccines Price by Type (2012-2017)
5.4 China Recombinant DNA Vaccines Production Growth by Type (2012-2017)
CHAPTER 6 CHINA RECOMBINANT DNA VACCINES MARKET ANALYSIS BY APPLICATION
6.1 China Recombinant DNA Vaccines Consumption and Market Share by Application (2012-2017)
6.2 China Recombinant DNA Vaccines Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
CHAPTER 7 CHINA RECOMBINANT DNA VACCINES MANUFACTURERS ANALYSIS
7.1 ALK - Abello A/S (Denmark)
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Product Type, Application and Specification
7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Business Overview
7.2 Altimmune, Inc. (US)
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Product Type, Application and Specification
7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Business Overview
7.3 Bavarian Nordic A/S (Denmark)
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Product Type, Application and Specification
7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Business Overview
7.4 BiondVax Pharmaceuticals Ltd. (Israel)
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Product Type, Application and Specification
7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Business Overview
7.5 Bharat Biotech International Limited (India)
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Business Overview
7.6 GlaxoSmithKline Plc. (UK)
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Product Type, Application and Specification
7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Business Overview
7.7 Hualan Biological Engineering Inc. (China)
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Product Type, Application and Specification
7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Business Overview
7.8 Janssen Pharmaceuticals, Inc. (US)
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Business Overview
7.9 MedImmune (US)
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Business Overview
CHAPTER 8 RECOMBINANT DNA VACCINES MANUFACTURING COST ANALYSIS
8.1 Recombinant DNA Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Recombinant DNA Vaccines
CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Recombinant DNA Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Recombinant DNA Vaccines Major Manufacturers in 2015
9.4 Downstream Buyers
CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
CHAPTER 12 CHINA RECOMBINANT DNA VACCINES MARKET FORECAST (2017-2021)
12.1 China Recombinant DNA Vaccines Production, Revenue Forecast (2017-2021)
12.2 China Recombinant DNA Vaccines Production, Consumption Forecast by Regions (2017-2021)
12.3 China Recombinant DNA Vaccines Production Forecast by Type (2017-2021)
12.4 China Recombinant DNA Vaccines Consumption Forecast by Application (2017-2021)
12.5 Recombinant DNA Vaccines Price Forecast (2017-2021)
CHAPTER 13 APPENDIX
1.1 Product Overview and Scope of Recombinant DNA Vaccines
1.2 Recombinant DNA Vaccines Market Segmentation by Type
1.2.1 China Production Market Share of Recombinant DNA Vaccines by Type 1n 2016
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Recombinant DNA Vaccines Market Segmentation by Application
1.3.1 Recombinant DNA Vaccines Consumption Market Share by Application in 2016
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Recombinant DNA Vaccines (2012-2021)
CHAPTER 2 CHINA ECONOMIC IMPACT ON RECOMBINANT DNA VACCINES INDUSTRY
2.1 China Macroeconomic Environment Analysis
2.1.1 China Macroeconomic Analysis
2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Recombinant DNA Vaccines Industry
CHAPTER 3 CHINA RECOMBINANT DNA VACCINES MARKET COMPETITION BY MANUFACTURERS
3.1 China Recombinant DNA Vaccines Production and Share by Manufacturers (2015 and 2016)
3.2 China Recombinant DNA Vaccines Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Recombinant DNA Vaccines Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Recombinant DNA Vaccines Manufacturing Base Distribution, Production Area and Product Type
3.5 Recombinant DNA Vaccines Market Competitive Situation and Trends
3.5.1 Recombinant DNA Vaccines Market Concentration Rate
3.5.2 Recombinant DNA Vaccines Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 CHINA RECOMBINANT DNA VACCINES CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)
4.1 China Recombinant DNA Vaccines Capacity, Production and Growth (2012-2017)
4.2 China Recombinant DNA Vaccines Revenue and Growth (2012-2017)
4.3 China Recombinant DNA Vaccines Production, Consumption, Export and Import (2012-2017)
CHAPTER 5 CHINA RECOMBINANT DNA VACCINES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
5.1 China Recombinant DNA Vaccines Production and Market Share by Type (2012-2017)
5.2 China Recombinant DNA Vaccines Revenue and Market Share by Type (2012-2017)
5.3 China Recombinant DNA Vaccines Price by Type (2012-2017)
5.4 China Recombinant DNA Vaccines Production Growth by Type (2012-2017)
CHAPTER 6 CHINA RECOMBINANT DNA VACCINES MARKET ANALYSIS BY APPLICATION
6.1 China Recombinant DNA Vaccines Consumption and Market Share by Application (2012-2017)
6.2 China Recombinant DNA Vaccines Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
CHAPTER 7 CHINA RECOMBINANT DNA VACCINES MANUFACTURERS ANALYSIS
7.1 ALK - Abello A/S (Denmark)
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Product Type, Application and Specification
7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Business Overview
7.2 Altimmune, Inc. (US)
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Product Type, Application and Specification
7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Business Overview
7.3 Bavarian Nordic A/S (Denmark)
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Product Type, Application and Specification
7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Business Overview
7.4 BiondVax Pharmaceuticals Ltd. (Israel)
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Product Type, Application and Specification
7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Business Overview
7.5 Bharat Biotech International Limited (India)
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Business Overview
7.6 GlaxoSmithKline Plc. (UK)
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Product Type, Application and Specification
7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Business Overview
7.7 Hualan Biological Engineering Inc. (China)
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Product Type, Application and Specification
7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Business Overview
7.8 Janssen Pharmaceuticals, Inc. (US)
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Business Overview
7.9 MedImmune (US)
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Business Overview
CHAPTER 8 RECOMBINANT DNA VACCINES MANUFACTURING COST ANALYSIS
8.1 Recombinant DNA Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Recombinant DNA Vaccines
CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Recombinant DNA Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Recombinant DNA Vaccines Major Manufacturers in 2015
9.4 Downstream Buyers
CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
CHAPTER 12 CHINA RECOMBINANT DNA VACCINES MARKET FORECAST (2017-2021)
12.1 China Recombinant DNA Vaccines Production, Revenue Forecast (2017-2021)
12.2 China Recombinant DNA Vaccines Production, Consumption Forecast by Regions (2017-2021)
12.3 China Recombinant DNA Vaccines Production Forecast by Type (2017-2021)
12.4 China Recombinant DNA Vaccines Consumption Forecast by Application (2017-2021)
12.5 Recombinant DNA Vaccines Price Forecast (2017-2021)
CHAPTER 13 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Recombinant DNA Vaccines
Figure China Production Market Share of Recombinant DNA Vaccines by Type 1n 2016
Table Recombinant DNA Vaccines Consumption Market Share by Application in 2016
Figure China Recombinant DNA Vaccines Revenue (Million USD) and Growth Rate (2012-2021)
Table China Recombinant DNA Vaccines Capacity of Key Manufacturers (2015 and 2016)
Table China Recombinant DNA Vaccines Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Recombinant DNA Vaccines Capacity of Key Manufacturers in 2015
Figure China Recombinant DNA Vaccines Capacity of Key Manufacturers in 2016
Table China Recombinant DNA Vaccines Production of Key Manufacturers (2015 and 2016)
Table China Recombinant DNA Vaccines Production Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant DNA Vaccines Production Share by Manufacturers
Figure 2016 Recombinant DNA Vaccines Production Share by Manufacturers
Table China Recombinant DNA Vaccines Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Recombinant DNA Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Recombinant DNA Vaccines Revenue Share by Manufacturers
Table 2016 China Recombinant DNA Vaccines Revenue Share by Manufacturers
Table China Market Recombinant DNA Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Recombinant DNA Vaccines Average Price of Key Manufacturers in 2015
Table Manufacturers Recombinant DNA Vaccines Manufacturing Base Distribution and Sales Area
Table Manufacturers Recombinant DNA Vaccines Product Type
Figure Recombinant DNA Vaccines Market Share of Top 3 Manufacturers
Figure Recombinant DNA Vaccines Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Recombinant DNA Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Recombinant DNA Vaccines Market Share (2012-2017)
Table ALK - Abello A/S (Denmark) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table ALK - Abello A/S (Denmark) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table ALK - Abello A/S (Denmark) Recombinant DNA Vaccines Market Share (2012-2017)
Table Altimmune, Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Altimmune, Inc. (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Altimmune, Inc. (US) Recombinant DNA Vaccines Market Share (2012-2017)
Table Bavarian Nordic A/S (Denmark) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bavarian Nordic A/S (Denmark) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Bavarian Nordic A/S (Denmark) Recombinant DNA Vaccines Market Share (2012-2017)
Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BiondVax Pharmaceuticals Ltd. (Israel) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table BiondVax Pharmaceuticals Ltd. (Israel) Recombinant DNA Vaccines Market Share (2012-2017)
Table Bharat Biotech International Limited (India) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bharat Biotech International Limited (India) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Bharat Biotech International Limited (India) Recombinant DNA Vaccines Market Share (2012-2017)
Table GlaxoSmithKline Plc. (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc. (UK) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc. (UK) Recombinant DNA Vaccines Market Share (2012-2017)
Table Hualan Biological Engineering Inc. (China) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hualan Biological Engineering Inc. (China) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Hualan Biological Engineering Inc. (China) Recombinant DNA Vaccines Market Share (2012-2017)
Table Janssen Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Pharmaceuticals, Inc. (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceuticals, Inc. (US) Recombinant DNA Vaccines Market Share (2012-2017)
Table MedImmune (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table MedImmune (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune (US) Recombinant DNA Vaccines Market Share (2012-2017)
Figure Production Revenue Share of Recombinant DNA Vaccines by Type (2012-2017)
Figure 2015 Revenue Market Share of Recombinant DNA Vaccines by Type
Table China Recombinant DNA Vaccines Price by Type (2012-2017)
Figure China Recombinant DNA Vaccines Production Growth by Type (2012-2017)
Table China Recombinant DNA Vaccines Consumption by Application (2012-2017)
Table China Recombinant DNA Vaccines Consumption Market Share by Application (2012-2017)
Figure China Recombinant DNA Vaccines Consumption Market Share by Application in 2015
Table China Recombinant DNA Vaccines Consumption Growth Rate by Application (2012-2017)
Figure China Recombinant DNA Vaccines Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant DNA Vaccines
Figure Manufacturing Process Analysis of Recombinant DNA Vaccines
Figure Recombinant DNA Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Recombinant DNA Vaccines Major Manufacturers in 2015
Table Major Buyers of Recombinant DNA Vaccines
Table Distributors/Traders List
Figure China Recombinant DNA Vaccines Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Recombinant DNA Vaccines Revenue and Growth Rate Forecast (2017-2021)
Table China Recombinant DNA Vaccines Production, Import, Export and Consumption Forecast (2017-2021)
Table China Recombinant DNA Vaccines Production Forecast by Type (2017-2021)
Table China Recombinant DNA Vaccines Consumption Forecast by Application (2017-2021)
COMPANIES MENTIONED
ALK - Abello A/S (Denmark)
Altimmune, Inc. (US)
Bavarian Nordic A/S (Denmark)
BiondVax Pharmaceuticals Ltd. (Israel)
Bharat Biotech International Limited (India)
GlaxoSmithKline Plc. (UK)
Hualan Biological Engineering Inc. (China)
Janssen Pharmaceuticals, Inc. (US)
MedImmune (US)
Merck & Co., Inc. (US)
Pfizer Inc. (US)
Sanofi Pasteur SA (France)
Serum Institute of India Pvt. Ltd. (India)
Shanghai BravoBio Co., Ltd. (China)
Seqirus (UK)
SK Chemicals Co., Ltd. (Korea)
Takeda Pharmaceutical Company Limited (Japan)
Zydus Cadila (India)
Figure Picture of Recombinant DNA Vaccines
Figure China Production Market Share of Recombinant DNA Vaccines by Type 1n 2016
Table Recombinant DNA Vaccines Consumption Market Share by Application in 2016
Figure China Recombinant DNA Vaccines Revenue (Million USD) and Growth Rate (2012-2021)
Table China Recombinant DNA Vaccines Capacity of Key Manufacturers (2015 and 2016)
Table China Recombinant DNA Vaccines Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Recombinant DNA Vaccines Capacity of Key Manufacturers in 2015
Figure China Recombinant DNA Vaccines Capacity of Key Manufacturers in 2016
Table China Recombinant DNA Vaccines Production of Key Manufacturers (2015 and 2016)
Table China Recombinant DNA Vaccines Production Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant DNA Vaccines Production Share by Manufacturers
Figure 2016 Recombinant DNA Vaccines Production Share by Manufacturers
Table China Recombinant DNA Vaccines Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Recombinant DNA Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Recombinant DNA Vaccines Revenue Share by Manufacturers
Table 2016 China Recombinant DNA Vaccines Revenue Share by Manufacturers
Table China Market Recombinant DNA Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Recombinant DNA Vaccines Average Price of Key Manufacturers in 2015
Table Manufacturers Recombinant DNA Vaccines Manufacturing Base Distribution and Sales Area
Table Manufacturers Recombinant DNA Vaccines Product Type
Figure Recombinant DNA Vaccines Market Share of Top 3 Manufacturers
Figure Recombinant DNA Vaccines Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Recombinant DNA Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Recombinant DNA Vaccines Market Share (2012-2017)
Table ALK - Abello A/S (Denmark) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table ALK - Abello A/S (Denmark) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table ALK - Abello A/S (Denmark) Recombinant DNA Vaccines Market Share (2012-2017)
Table Altimmune, Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Altimmune, Inc. (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Altimmune, Inc. (US) Recombinant DNA Vaccines Market Share (2012-2017)
Table Bavarian Nordic A/S (Denmark) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bavarian Nordic A/S (Denmark) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Bavarian Nordic A/S (Denmark) Recombinant DNA Vaccines Market Share (2012-2017)
Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BiondVax Pharmaceuticals Ltd. (Israel) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table BiondVax Pharmaceuticals Ltd. (Israel) Recombinant DNA Vaccines Market Share (2012-2017)
Table Bharat Biotech International Limited (India) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bharat Biotech International Limited (India) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Bharat Biotech International Limited (India) Recombinant DNA Vaccines Market Share (2012-2017)
Table GlaxoSmithKline Plc. (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc. (UK) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc. (UK) Recombinant DNA Vaccines Market Share (2012-2017)
Table Hualan Biological Engineering Inc. (China) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hualan Biological Engineering Inc. (China) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Hualan Biological Engineering Inc. (China) Recombinant DNA Vaccines Market Share (2012-2017)
Table Janssen Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Pharmaceuticals, Inc. (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceuticals, Inc. (US) Recombinant DNA Vaccines Market Share (2012-2017)
Table MedImmune (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table MedImmune (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune (US) Recombinant DNA Vaccines Market Share (2012-2017)
Figure Production Revenue Share of Recombinant DNA Vaccines by Type (2012-2017)
Figure 2015 Revenue Market Share of Recombinant DNA Vaccines by Type
Table China Recombinant DNA Vaccines Price by Type (2012-2017)
Figure China Recombinant DNA Vaccines Production Growth by Type (2012-2017)
Table China Recombinant DNA Vaccines Consumption by Application (2012-2017)
Table China Recombinant DNA Vaccines Consumption Market Share by Application (2012-2017)
Figure China Recombinant DNA Vaccines Consumption Market Share by Application in 2015
Table China Recombinant DNA Vaccines Consumption Growth Rate by Application (2012-2017)
Figure China Recombinant DNA Vaccines Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant DNA Vaccines
Figure Manufacturing Process Analysis of Recombinant DNA Vaccines
Figure Recombinant DNA Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Recombinant DNA Vaccines Major Manufacturers in 2015
Table Major Buyers of Recombinant DNA Vaccines
Table Distributors/Traders List
Figure China Recombinant DNA Vaccines Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Recombinant DNA Vaccines Revenue and Growth Rate Forecast (2017-2021)
Table China Recombinant DNA Vaccines Production, Import, Export and Consumption Forecast (2017-2021)
Table China Recombinant DNA Vaccines Production Forecast by Type (2017-2021)
Table China Recombinant DNA Vaccines Consumption Forecast by Application (2017-2021)
COMPANIES MENTIONED
ALK - Abello A/S (Denmark)
Altimmune, Inc. (US)
Bavarian Nordic A/S (Denmark)
BiondVax Pharmaceuticals Ltd. (Israel)
Bharat Biotech International Limited (India)
GlaxoSmithKline Plc. (UK)
Hualan Biological Engineering Inc. (China)
Janssen Pharmaceuticals, Inc. (US)
MedImmune (US)
Merck & Co., Inc. (US)
Pfizer Inc. (US)
Sanofi Pasteur SA (France)
Serum Institute of India Pvt. Ltd. (India)
Shanghai BravoBio Co., Ltd. (China)
Seqirus (UK)
SK Chemicals Co., Ltd. (Korea)
Takeda Pharmaceutical Company Limited (Japan)
Zydus Cadila (India)
